Elliott Investment opposes Swedish Match's acquisition by Philip Morris International

Jul.11.2022
Elliott Investment opposes Swedish Match's acquisition by Philip Morris International
Elliott Investment Management is opposing the sale of Swedish Match AB to Philip Morris for $16 billion.

According to sources familiar with the matter, Elliott Investment Management is building a stake in Swedish Match AB. Swedish Match AB is a smokeless tobacco company that has agreed to be sold to Philip Morris International for $16 billion.


According to insiders, a US activist investor is reportedly planning to oppose the current terms of the deal and has requested that their identity remains confidential. Swedish Match had previously agreed in May to be acquired by PhiMo International.


A representative of Elliott declined to comment. Representatives from Swedish Match and Fempro International were unable to be reached for immediate comment.


On Friday, the stock price of Swedish Match increased by 1.7%, causing the company's market value to reach 161.3 billion kronor ($15.2 billion).


This transaction is subject to many conditions, including Fimo International acquiring over 90% of Swedish Match's shares through a bid, unless it chooses to waive this condition. At the end of last year, AstraZeneca Plc withheld 8% of Biovitrum AB's shares from its acquisition by Advent International and Singapore's GIC Pte, effectively preventing the purchase for $7.6 billion, highlighting the impact of opposition from major shareholders.


Freeze shares.


According to analyst Mads Rosendal of Danske Bank A/S, it is unlikely that Elliott will be able to acquire a large enough stake in Swedish Match to single-handedly block the deal.


In a research report on Friday, he wrote, "Even if they successfully block this transaction, it may not be detrimental to Swedish Match's profitability.


According to Rosendal, if the original agreement is reached, Swedish Match would be better off from a financial and credit rating perspective, but would suffer damage in terms of environmental, social, and governance considerations.


The Swedish Match deal is one of the biggest transactions this year, pushing FeiMo International into the fiercely competitive market for oral nicotine products, many of which are very different from traditional chewing tobacco.


Swedish Match is a prominent manufacturer of snuff, a tobacco product that users place between their upper lip and gum. It is popular in Sweden but banned in other parts of Europe. The company also produces nicotine pouches known as ZYN.


In recent years, Elliot Management Corporation, run by billionaire Paul Singer, has been concerned with the changes taking place in some of the world's largest and most well-known companies, including Twitter, Canadian National Railway and American multinational conglomerate AT&T. In Europe, the company last year drove the transformation of pharmaceutical firm GSK Plc and energy company SSE Plc.


I'm sorry, as an AI language model, I already operate and communicate in standard journalistic English. If you have a specific sentence or text that you want me to translate, please provide it.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Ukrainian Committee Chair Says Nicotine Pouches Should Be Fully Banned for Sale to Minors
Mykhailo Radutskyi, chair of the Verkhovna Rada Committee on National Health, Medical Assistance and Medical Insurance, said nicotine pouches should be fully banned for sale to minors and their advertising should be restricted.
Apr.07 by 2FIRSTS.ai
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
According to Beritasatu, Commission III of the Indonesian House of Representatives is reviewing the Draft Law on Narcotics and Psychotropics and considering including a proposal from the National Narcotics Agency (BNN) to ban vapes.
Apr.10 by 2FIRSTS.ai
 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
U.S. Company Seeks Cancellation of “Lost Mary” Vape Trademark
North Carolina hemp provider JLT Imports Inc. has filed suit in California federal court seeking cancellation of the “Lost Mary” vape trademark held by Chinese company Imiracle (HK) Ltd.
Mar.30 by 2FIRSTS.ai
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes
South Korea’s Ministry of Food and Drug Safety said on April 17 that it has additionally designated the International Characterization Research Institute as a tobacco harmful components testing body under the Act on the Management of Tobacco Harmfulness. The institute has research experience in analyzing harmful components in liquid e-cigarettes and has obtained recognition for tobacco-sector ISO 17025 requirements.
Apr.17 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai